Asthma and Bowen Therapy

Between 2003 and 2004, Nikke Ariff tested the efficacy of Bowen in treating asthma. This research, carried out during a twelve-month period, included a majority of participants who had asthma for over 5 years, and most, over 15 years. The results were positive. Eighty-three percent reported a reduction in the frequency of asthma attacks with 75% reporting less reliance on medication following Bowen treatments.

Of 24 volunteers who completed the program, 22 reported that secondary health concerns had also improved, including back, neck and shoulder pain; knee and joint problems; headaches and migraines; hay fever; irritable bowel syndrome; poor digestion; poor circulation; insomnia; anxiety, stress, depression; and reduced energy levels.